A large delegation from BBT attends ESB 2026

Sep 15, 2026

Eleven of the fifty researchers who are part of the BBT research group have participated in the 35th Annual Conference of the European Society for Biomaterials, a landmark meeting coinciding with the 50th anniversary of the institution's founding.

The Research Group in Biomaterials, Biomechanics and Tissue Engineering (BBT) demonstrates its role as an international benchmark in bioengineering with a large delegation attending the 35th Annual Conference of the European Society for Biomaterials (ESB 2026). A team of eleven out of its fifty researchers traveled to present the latest advances developed in their laboratories.

This year's scientific gathering carries a particularly symbolic meaning, marking the 50th anniversary of the founding of the European Society for Biomaterials. Since its inception, the ESB has led the evolution of a field that has transitioned from designing basic synthetic implants to developing advanced solutions for regenerative medicine, 3D bioprinting, and smart medical devices.

This attendance by BBT—representing 20% of its research staff—highlights both the group's intense activity in the field and its commitment to outreach and international collaboration. Specifically, BBT members gave the following presentations:

  • R. Agut López, M.P. Ginebra, M. Espanol Pons. Flexible Ceramic Hydroxyapatite Scaffolds with Tuneable Mechanical Properties and Degradation Kinetics. Poster Presentation.
  • A. Caballeria-Casals, G. Fornabaio, A. Espona-Noguera, F. Sanus, C. Peralta, C. Canal. New Hydrogel Vehicles for Reactive Oxygen and Nitrogen Target Tumorigenesis and Liver Damage In Vivo. A. Caballeria-Casals, G. Fornabaio, A. Espona-Noguera, F. Sanus, C. Peralta, C. Canal. New Hydrogel Vehicles for Reactive Oxygen and Nitrogen Target Tumorigenesis and Liver Damage In Vivo. Oral  Presentation.
  • M. Cano-Morenilla, V. Chausse, M. Pino, M. Díaz-Ricart, M. Balcells, C. Mas-Moruno, M. Pegueroles, Surface modification of bioresorbable polymers for opposite thrombogenic responses in stents and coils. Oral Presentation.
  • A. Fajardo-García, J. Guasch, J. Garcia-Torres. Tunable gelatin-chitosan hydrogels for lymph node-inspired 3D models in cancer immunotherapy. Oral Presentation.
  • A. Viteri, S. Colombi, L. Resina, M.-P. Ginebra, E. Engel, C. Alemán, J. García-Torres. Magnetoelectric GelMA-Graphene Hydrogels for Remote Cardiac Stimulation and Sensing. Oral Presentation.
  • J. Grzelak, M. Iglesias-Fernández, T.P. Thompson, C. Biscaut, L. Ceccarelli, B.F. Gilmore, M.P. Ginebra. Nanostructured bioceramic surfaces potentiate antibiotic efficacy against P. aeruginosa. Oral  Presentation.
  • N. Mehwish, J. Sánchez Homs, P. López-Gómez, M.-P. Ginebra, C. Mas-Moruno. Thiol-guided peptide-functionalized albumin hydrogels with tunable architecture and bioactivity. Oral presentation.
  • A.A. Menarbazari, J. Grzelak, M.P. Ginebra. Mechanically induced bactericidal effects of nanostructured hydroxyapatite and titanium surfaces under static and dynamic conditions for bone tissue engineering. Oral Presentation. 
  • R.S. Nunes, C.A. Marzenta, A.A. Menarbazari, A.R. Sorribas, V.D.P. Cinel, G.C. Battistini, R.A.G. Silva, A.B. Seabra, M.P. Ginebra. Balancing cytocompatibility and antimicrobial performance in chemometrically optimized chitosan-stabilitzed sulfur nanoparticles. Poster Presentation.
  • M. Cano-Morenilla, M. Pino, M. Díaz-Ricart, X. Wang, D. Baker, M. Pegueroles, J. Guillem-Marti. NeoNectin-functionalized 3D-printed polymeric stents promote endothelialisation and reduce thrombogenicity. Oral Presentation.
  • A. Ruiz-Sorribas, F. Tampieri, C. Canal, M.P. Ginebra. Fighting bacterial colonization of hydroxyapatite: the role of nanotopography and plasma-treated liquids. Oral Presentation.
  • F. Tabatabaei Koupaei, T. Morel, M.P. Ginebra, M. Espanol. Ultra-long Ion-doped Hydroxyapatite Nanofibers: from Brittle Ceramics to Flexible Bioactive Scaffolds. Poster Presentation.